June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Identification of a novel UBIAD1 mutation in an individual with Schnyder corneal dystrophy
Author Affiliations & Notes
  • Stephan Chiu
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Benjamin Ray Lin
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Anthony J Aldave
    Ophthalmology, Jules Stein Eye Institute, UCLA, Los Angeles, CA
  • Footnotes
    Commercial Relationships Stephan Chiu, None; Benjamin Lin, None; Anthony Aldave, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2531. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Stephan Chiu, Benjamin Ray Lin, Anthony J Aldave; Identification of a novel UBIAD1 mutation in an individual with Schnyder corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2531.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To report the identification of a novel missense mutation in the UBIAD1 gene in an individual with a corneal phenotype consistent with Schnyder corneal dystrophy (SCD).

Methods: A slit lamp examination was performed on a 47-year-old woman of mixed Asian and Caucasian descent without a family history of corneal disorders. After informed consent was obtained, genomic DNA was isolated from saliva. The exons and exon-intron boundaries of the UBIAD1 gene were screened using Sanger sequencing. Identified variants were screened for in 100 control individuals. Polyphen-2 and SIFT were used to predict the functional impact of the identified mutations.

Results: Slit lamp examination revealed prominent bilateral corneal arcus, 4.0 mm central, discoid panstromal opacification and central superficial crystalline deposition. Screening of UBIAD1 identified a novel heterozygous c.308 C>T mutation, predicted to encode a missense p.(Thr103Ile) substitution. This mutation was not identified in 200 control chromosomes. Polyphen-2 and SIFT both predicted p.(Thr103Ile) to be damaging to normal protein function.

Conclusions: We present a novel heterozygous missense mutation in UBIAD1 identified in a patient with SCD. The p.(Thr103Ile) mutation is located in exon 1, in which the majority of previously reported mutations have been identified. Given the reported negative family history, screening of the proband’s parents is expected to demonstrate whether this represents the first confirmed de novo UBIAD1 mutation associated with SCD.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×